Synthesis of a new class of furan-fused tetracyclic compounds using o-quinodimethane chemistry and investigation of their antiviral activity

Journal of Organic Chemistry

Volumn 69, Issue 23, 2004, Pages 7989-7993

  Matsuya, Yuji ^a,b   Sasaki, Kazushige ^a   Nagaoka, Mamiko ^a,b   Kakuda, Hiroko ^a   Toyooka, Naoki ^a,b   Imanishi, Nobuko ^a   Ochiai, Hiroshi ^a,b   Nemoto, Hideo ^a,b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b TOMECS ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DERIVATIVES; DRUG DOSAGE; METHANE; SUBSTRATES;

BENZOCYCLOBUTENE DERIVATIVES; TETRACYCLIC COMPOUNDS;

SYNTHESIS (CHEMICAL);

ALICYCLIC HYDROCARBON; ANTIVIRUS AGENT; BENZOCYCLOBUTENE; FURAN DERIVATIVE; HEMAGGLUTININ; METHANE; POLYCYCLIC HYDROCARBON; QUINODIMETHANE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CYCLOADDITION; DRUG STRUCTURE; DRUG SYNTHESIS; STEREOCHEMISTRY; VIROGENESIS;

ANIMALS; ANTIVIRAL AGENTS; CELLS, CULTURED; CYCLIZATION; FURANS; HAPLORHINI; HEMAGGLUTINATION TESTS; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; KIDNEY; MOLECULAR STRUCTURE;

EID: 8644255065     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0486995     Document Type: Article

References (16)

1. (a) Lee, R. H.; Slate, D. L.; Moretti, R.; Alvi, K. A.; Crews, P. Biochem. Biophys. Res. Commun. 1992, 184, 765-772.
2. (b) Alvi, K. A.; Diaz, M. C.; Crews, P.; Slate, D. L.; Lee, R. H.; Moretti, R. J. Org. Chem. 1992, 57, 6604-6607.
3. (a) Roll, D. M.; Scheuer, P. J.; Matsumoto, G. K.; Claedy, J. J. Am. Chem. Soc. 1983, 105, 6177-6178.
4. (b) Kobayashi, M.; Shimizu, N.; Kyogoku, Y.; Kitagawa, I. Chem. Pharm. Bull. 1985, 33, 1305-1038.
5. (c) Kobayashi, M.; Shimizu, N.; Kitagawa, I.; Kyogoku, Y.; Harada, N.; Uda, H. Tetrahedron Lett. 1985, 26, 3833-3836.
6. (d) Nakamura, H.; Kobayashi, J.; Kobayashi, M.; Ohizumi, Y.; Hirata, Y. Chem. Lett. 1985, 713-716.
7. (e) Schmits, F. J.; Bloor, S. J. Org. Chem. 1988, 53, 3922-3925.
8. (a) Toyooka, N.; Nagaoka, M.; Kakuda, H.; Nemoto, H. Synlett 2001, 1123-1124.
9. (b) Toyooka, N.; Nagaoka, M.; Sasaki, E.; Qin, H.; Kakuda, H.; Nemoto, H. Tetrahedron 2002, 58, 6097-6101.
10. (c) Matsuya, Y.; Qin, H.; Nagaoka, M.; Nemoto, H. Heterocycles 2004, 62, 207-211.
11. Nemoto, H.; Fukumoto, K. Tetrahedron 1998, 54, 5425-5464.
12. Racherla, U. S.; Brown, H. C. J. Org. Chem. 1992, 57, 6614-6617.
13. 13C NMR) and on the TLC, so the ratio of the diastereomers could not be estimated. It should be noted that the diastereomeric ratio of the starting materials 8 does not reflect the product ratio of 9 and 9′ (or 10) because the chiral center bearing the cyano group in 8 is canceled out during formation of the o-quinodimethane intermediate.
14. Details of the crystallographic data are provided in the Supporting Information.
15. Ochiai, H.; Sakai, S.; Hirabayashi, T.; Shimizu, Y.; Terasawa, K. Antiviral Res. 1995, 27, 425-430.
16. Mosmann, T. J. Immunol. Methods 1983, 65, 55-63.